Loading...
Immunogenicity, Safety, and Reactogenicity of a Half- Versus Full-Dose BNT162b2 (Pfizer-Biontech) Booster Following a Two-Dose ChAdOx1 nCoV-19, BBIBP-CorV, or Gam-COVID-Vac Priming Schedule in Mongolia: A Randomised, Controlled, Non-Inferiority Trial
Зохиогч
Batmunkh, Tsetsegsaikhan
Moore, Kerryn
Thomson, Helen
Altangerel, Bolor
Amraa, Otgonjargal
Avaa, Naranbaatar
Batbayar, Lkhagvagaram
Batsukh, Khishigjargal
Bright, Kathryn
Burentogtokh, Tsogjargal
Do, Lien Anh Ha
Hart, John D.
Javkhlantugs, Khulan
Jigjidsuren, Sarantsetseg
Justice, Frances
Li, Shuo
Licciardi, Paul V.
Mashbaatar, Khaliunaa
Mazarakis, Nadia
Neal, Eleanor FG
Nguyen, Cattram D.
Ochirbat, Batbayar
Tuya, Alimaa
Surenjav, Unursaikhan
von Mollendorf, Claire
Mulholland, Kim
Он
2023
Төрөл
other
Хэвлэгч
Elsevier BV